ExodusPoint Capital Management’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-55,845	Closed	-$278K	–	1923
2024 Q3	$278K	Buy	+55,845	New	+$278K	﹤0.01%	1283
2024 Q2	–	Sell	-35,661	Closed	-$283K	–	1830
2024 Q1	$283K	Sell	35,661 -28,117	-44%	-$223K	﹤0.01%	1148
2023 Q4	$372K	Buy	+63,778	New	+$372K	﹤0.01%	1045